FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well FR901228 works in treating patients with relapsed or
refractory non-Hodgkin's lymphoma. Drugs used in chemotherapy, such as FR901228, work in
different ways to stop tumor cells from dividing so they stop growing or die.